KR20050032050A - Culture method of chlorella containing selenium and germanium - Google Patents
Culture method of chlorella containing selenium and germanium Download PDFInfo
- Publication number
- KR20050032050A KR20050032050A KR1020050011806A KR20050011806A KR20050032050A KR 20050032050 A KR20050032050 A KR 20050032050A KR 1020050011806 A KR1020050011806 A KR 1020050011806A KR 20050011806 A KR20050011806 A KR 20050011806A KR 20050032050 A KR20050032050 A KR 20050032050A
- Authority
- KR
- South Korea
- Prior art keywords
- germanium
- selenium
- chlorella
- organic
- chelated
- Prior art date
Links
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 title claims abstract description 93
- 229910052732 germanium Inorganic materials 0.000 title claims abstract description 90
- 239000011669 selenium Substances 0.000 title claims abstract description 62
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 60
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 60
- 241000195649 Chlorella <Chlorellales> Species 0.000 title claims abstract description 34
- 238000012136 culture method Methods 0.000 title claims 2
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 15
- 229930003231 vitamin Natural products 0.000 claims abstract description 15
- 229940088594 vitamin Drugs 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 14
- 244000005700 microbiome Species 0.000 claims abstract description 13
- YBMRDBCBODYGJE-UHFFFAOYSA-N germanium oxide Inorganic materials O=[Ge]=O YBMRDBCBODYGJE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 238000012258 culturing Methods 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 12
- 229910005793 GeO 2 Inorganic materials 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 abstract description 15
- 230000003078 antioxidant effect Effects 0.000 abstract description 7
- 230000001093 anti-cancer Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 231100000956 nontoxicity Toxicity 0.000 abstract description 3
- 229910003424 Na2SeO3 Inorganic materials 0.000 abstract description 2
- 239000011655 sodium selenate Substances 0.000 abstract description 2
- 235000018716 sodium selenate Nutrition 0.000 abstract description 2
- 239000011781 sodium selenite Substances 0.000 abstract description 2
- 235000015921 sodium selenite Nutrition 0.000 abstract description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 235000011649 selenium Nutrition 0.000 description 44
- 206010028980 Neoplasm Diseases 0.000 description 19
- 201000011510 cancer Diseases 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 238000011160 research Methods 0.000 description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 6
- -1 antioxidant power Chemical compound 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000002177 Cataract Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010027439 Metal poisoning Diseases 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229910001385 heavy metal Inorganic materials 0.000 description 4
- 208000008127 lead poisoning Diseases 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 210000001539 phagocyte Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 230000004199 lung function Effects 0.000 description 3
- 150000002736 metal compounds Chemical class 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 2
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 102000009025 Endorphins Human genes 0.000 description 1
- 108010049140 Endorphins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940043215 aminolevulinate Drugs 0.000 description 1
- 229960002749 aminolevulinic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052800 carbon group element Inorganic materials 0.000 description 1
- 150000001724 carbon group elements Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002799 interferon inducing agent Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 125000000082 organogermanium group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- PVADDRMAFCOOPC-UHFFFAOYSA-N oxogermanium Chemical compound [Ge]=O PVADDRMAFCOOPC-UHFFFAOYSA-N 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001173 tumoral effect Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Abstract
Description
본 발명은 유기 셀레늄과 게르마늄이 동시에 함유된 클로렐라의 배양방법에 관한 것으로, 본 발명에 따라 배양되는 클로렐라에는 인체에 독성이 없고 흡수율이 높은 유기 셀레늄과 게르마늄이 함유되어 있어 현대인에게 부족한 자연 치유물질인 셀레늄과 게르마늄의 알려진 기능인 항산화력, 심장과 폐기능 향상, 노폐물질의 분해, 간경화증 예방, 면역기능 향상, 성적기능 향상, 근이 영양증 치료, 항암 예방에 기여할 수 있다.The present invention relates to a method of culturing chlorella containing both organic selenium and germanium. The chlorella cultivated according to the present invention contains organic selenium and germanium, which are not toxic to the human body and have high absorption rate, which is a natural healing substance lacking in modern people. Known functions of selenium and germanium, such as antioxidant power, improve heart and lung function, breakdown of waste materials, prevent cirrhosis, improve immune function, improve sexual function, treat muscle nutrition and prevent cancer.
최근에는 원하는 영양소나 원소 또는 물질을 기존의 농축산물에 함유시켜 영양학적 부가가치를 높이려는 노력이 계속되고 있다. 그 대표적인 예가 유기 또는 무기상태의 셀레늄, 게르마늄을 식물에 비료로 공급하여 식물을 통해 다시 한번 유기화 과정을 거친 후 식물에 농축시켜 인체에 필요한 유효 농도의 셀레늄과 게르마늄의 알려진 성분인 항암, 항산화 성분을 섭취하려하고 있으며, 또한 육류 및 유류 등의 축산물에서도 특정의 유용성분을 축적시키려는 시도가 있다.Recently, efforts have been made to increase nutritional added value by adding desired nutrients, elements or substances to existing agricultural products. A typical example is the supply of organic or inorganic selenium and germanium as fertilizers to plants, and after the organic process through the plants once again concentrated in the plant to the effective concentrations of selenium and germanium known to the human body, anti-cancer and antioxidant components There are also attempts to accumulate certain useful ingredients in livestock products such as meat and oil.
셀레늄은 화학주기율표상 6B족에 속하는 원소로서 원자번호 34, 원소기호 Se, 원자량 78.96의 맥주효모, 돼지 및 소의 콩팥, 버터, 소아맥아, 굴, 새우, 우유, 현미 그리고 마늘에 다량 함유되어 있다. 사람 등의 동물체 내에서는 주로 셀레노시스테인과 셀레노메치오닌 등의 셀레노 아미노산 형태로 존재하며, 이들은 세포막의 손상을 야기하는 과산화수소를 제거하는 작용을 하는 글루타치온 퍼옥시다제를 활성화시켜 세포막의 과산화적 손상을 방지하여 종양성 질환을 예방하는 작용을 가진 것으로 알려져 있다. 많은 연구에서 셀레늄은 종양질환을 억제하는 효과가 있는 것으로 알려지고 있는데 이는 많은 암환자에서 혈청내 셀레늄 농도가 비정상적으로 낮게 나타나는 것과 연관이 있다고 생각되고 있다. 또한 납중독에 의한 빈혈현상은 납이 적혈구의 용혈작용과 헤모글로빈 합성에 관여하는 S-아미노레불린산데하이드라제(ALAD) 효소의 활성을 저해하여 아미노레불린산의 요로의 배설을 증가시킴으로써 조혈작용을 저해할 뿐 아니라, 납이 ALAD의 SH기를 불활성화시켜 조혈기능이 악화됨으로써 발생하는 것으로 알려져 있다. 이러한 납중독도 생체내 항산화제로 알려진 셀레늄에 의해 해독될 수 있다는 보고가 있는데, 이는 납에 의해 활성이 약화된 셀레늄-의존성 항산화계 효소인 글루타치온퍼록시다제가 셀레늄 보충으로 그 활성이 현저하게 증가되기 때문으로 생각되어진다. 이는 흰쥐의 납중독시에 식이내 셀레늄을 0.5ppm의 농도로 첨가하면, 비첨가군에 비하여 간장조직의 과산화적 손상이 감소되는 결과가 있기 때문이다. 셀레늄의 이러한 납중독 해독작용은 ALAD의 SH기가 SeH로 치환됨으로써 납에 의한 SH기의 불활성화가 방지되기 때문인 것으로 설명되고 있다. 기타 유사한 기전에 의해 셀레늄은 납 이외에도 카드뮴, 수은 등의 중금속 해독에도 효과가 있다고 보고되어 있다. 이들 이외의 셀레늄의 작용효과를 요약해 보면 다음과 같다:Selenium is an element belonging to group 6B of the chemical periodic table and is contained in abundance in atomic number 34, element symbol Se, brewer's yeast of atomic weight 78.96, pork and beef kidney, butter, infant malt, oyster, shrimp, milk, brown rice and garlic. In animals such as humans, they are mainly present in the form of seleno amino acids such as selenocysteine and selenomethionine, and they activate glutathione peroxidase, which acts to remove hydrogen peroxide, which causes damage to the cell membrane. It is known to have the effect of preventing tumoral disease by preventing. In many studies, selenium has been shown to have an inhibitory effect on tumor disease, which is thought to be associated with abnormally low serum levels of selenium in many cancer patients. In addition, anemia caused by lead poisoning is a hematopoietic effect by increasing the excretion of the urinary tract of aminolevulinic acid by inhibiting the activity of S-aminolevulinate dehydrase (ALAD) enzyme, which is involved in hemolytic action of hemoglobin and hemoglobin synthesis. In addition to inhibiting, it is known that lead is caused by inactivation of the SH group of ALAD and deterioration of hematopoietic function. It has been reported that lead poisoning can also be detoxified by selenium, which is known as an antioxidant in vivo, because glutathione peroxidase, a selenium-dependent antioxidant enzyme whose activity is weakened by lead, is significantly increased by selenium supplementation. It is thought to be. This is because, when lead poisoning in rats is added to the diet of selenium at a concentration of 0.5 ppm, hepatic tissue peroxidation damage is reduced as compared to the non-added group. This lead poisoning detoxification of selenium is explained because the SH group of ALAD is replaced with SeH, thereby preventing the inactivation of SH group by lead. Other similar mechanisms have reported that selenium is effective in the detoxification of heavy metals such as cadmium and mercury in addition to lead. A summary of the effects of selenium other than these are as follows:
·셀레늄의 항산화력은 토코페롤의 1975배에 달하며 토코페롤과 셀레늄을 병용하면 상승효과가 나타난다.The antioxidant power of selenium is 1975 times that of tocopherol, and synergistic effect occurs when tocopherol and selenium are used together.
·비듬과 건선에 치료효과를 나타내며 산소의 이용률을 증가시켜 심장과 폐기능을 높여준다.· It has a therapeutic effect on dandruff and psoriasis and increases the utilization of oxygen to improve heart and lung function.
·비타민 C 및 E와 같이 불포화지방산의 산화를 억제하여 과산화지질의 생성을 억제할 뿐 아니라, 과산화지질과 단백질의 결합물인 노폐물질을 분해한다.It inhibits the oxidation of unsaturated fatty acids such as vitamins C and E, which not only suppresses the production of lipid peroxide, but also decomposes waste materials that are a combination of lipid peroxide and protein.
·수은, 카드늄, 납 등의 중금속과 결합하여 이들을 불활성화 시키고 간세포의 괴사를 방지하여 간경화증을 예방한다.It combines with heavy metals such as mercury, cadmium and lead to inactivate them and prevents necrosis of liver cells to prevent cirrhosis.
·면역기능을 향상시키고 상당량(약 25 내지 40%)이 남성의 고환, 정낭, 전립선 등의 성기관에 지붕되어 성적기능을 향상시킨다.Improves immune function and a significant amount (approximately 25-40%) is roofed in male sex organs such as testicles, seminal vesicles and prostate gland to improve sexual function.
·백내장과 류마치스 관절염을 예방하며 비타민 E와 상승작용을 일으켜 근이 영양증(muscular dystrophy)에 효과가 있다.Prevents cataracts and rheumatoid arthritis and synergizes with vitamin E. Muscle is effective for muscular dystrophy.
·인체의 노화를 지연시키고 암을 예방하며 폐와 심장기능을 향상시킨다.Delays aging of the human body, prevents cancer and improves lung and heart function
게르마늄은 주기율표 4B족에 속하는 탄소족원소의 하나. 원소기호 Ge, 원자번호 32, 원자량 72.59%로 먹는 산소로 알려져 있다.Germanium is one of the carbon group elements belonging to group 4B of the periodic table. It is known as the elemental symbol Ge, atomic number 32, and oxygen for which the atomic weight is 72.59%.
순도가 높은 유기게르마늄은 복용 후 인체 내에서 각종 임무를 마친 후 약 20-30시간 안에 인체 내에 있는 암 세포, 독소, 오염물질, 중금속 등을 붙들고 축적되는 것 없이 소변을 통해 인체에서 완전히 빠져나가므로 전혀 독성이 남지 않아 매우 안전하다.High-purity organic germanium completely escapes from the human body through urine without holding and accumulating cancer cells, toxins, contaminants, and heavy metals in the human body within about 20-30 hours after taking various tasks in the human body after taking them. It is very safe because there is no toxicity at all.
Source: Asai Germanium Research Institute, Tokyo, Japan.Source: Asai Germanium Research Institute, Tokyo, Japan.
동물실험 28일과 6개월 1mg/㎏/Day 투여하며 정밀 관찰 결과 6개월 마지막에 수놈에게서 아주 약간의 무게가 줄어든 것 외에는 어떤 특별한 독성이나 중독 현상이 없었으며 동작이나 행동에도 이상이 발견되지 않았다. 뿐만 아니라 게르마늄은 복용하는 대로 소변을 따라 배출되기 때문에 6개월 후의 검사에서 어느 기관에서도 축적이나 중독 증상이 없었다.On the 28th and 6th month of the animal experiment, 1mg / kg / Day was administered and the result of close observation showed no special toxicity or poisoning phenomenon except for the slight loss of weight in the male at the end of 6 months. In addition, because germanium is excreted in the urine as it is taken, there were no symptoms of accumulation or poisoning in any organ after 6 months of testing.
Source: Journal de Toxicologie Clinique et Experimental Dec. 11, 1991(7-8) 421-36-Source: Journal de Toxicologie Clinique et Experimental Dec. 11, 1991 (7-8) 421-36-
유기게르마늄(Ge-132)은 세포들의 부상(상해)을 예방Organo germanium (Ge-132) prevents injury to cells
게르마늄(Ge-132)은 상해(부상)를 입은 세포들에 대한 효과의 동물실험 연구에서 게르마늄(Ge-132)을 투여한 동물들의 세포들의 부상에 대한 예방과 스스로 치료되어지는 것을 발견하였다. 이 모든 효과들은 게르마늄(Ce-132)의 역할과 관련이 있다. 이러한 결과들은 게르마늄(Ge-132)이 세포들의 원활한 신진대사를 촉진하여 그것이 부상으로부터 보호되고 있는 것으로 보여진다.Germanium (Ge-132) has been found in animal studies of the effects on injured cells to prevent self-treatment and prevent the injury of cells in animals given Germanium (Ge-132). All these effects are related to the role of germanium (Ce-132). These results show that germanium (Ge-132) promotes smooth metabolism of cells, which is protected from injury.
Source: Yao Hsueh Hsueh Pao Acta Pharmaceutica Sinica, 1992, 27(7):481-5Source: Yao Hsueh Hsueh Pao Acta Pharmaceutica Sinica, 1992, 27 (7): 481-5
만성 피로를 완화시켜 주는 개체로써의 게르마늄(Ge-132)Germanium as an Individual to Alleviate Chronic Fatigue (Ge-132)
게르마늄이 바이러스성의 만성피로 증후군(Chronic Epstein-Barr Virus Syndrome)의 증상을 약화시키고 완화시켜 준다는 사실이 발견되었다. 수백만의 미국인은 물론 세계 각국의 많은 사람들이 이 바이러스성의 만성피로 증후군(Chronic Epstein-Barr Virus Syndrome)으로 고통 받고 있다.Germanium has been found to attenuate and alleviate the symptoms of the Chronic Epstein-Barr Virus Syndrome. Millions of Americans, as well as many people around the world, suffer from this chronic Epstein-Barr Virus Syndrome.
Source: Use of Organic Germanium in Chronic Epstein-Barr Virus Syndrome,' Journal of Orthomolecular Medicine, 1989Source: Use of Organic Germanium in Chronic Epstein-Barr Virus Syndrome, 'Journal of Orthomolecular Medicine, 1989
게르마늄은 백내장의 진전을 늦춘다, Ge-132는 백내장의 진전을 늦췄으며, 백내장의 예방과 치료에도 좋은 효과를 보였다.Germanium slows the development of cataracts, Ge-132 slows the development of cataracts, and has been shown to be effective in the prevention and treatment of cataracts.
Source: Department of Biological Sciences, Oakland University,Source: Department of Biological Sciences, Oakland University,
Rochester, MI, Experimental Eye Research, August 1995.'Rochester, MI, Experimental Eye Research, August 1995. '
돌연변이성 인자의 억제제로써의 게르마늄Germanium as an inhibitor of mutagenic factor
많은 연구들이나 논문 등에서는 평상시 여러 가지 필수 영양소들을 골고루 섭취하기를 권한다. 특히 산화방지제, 비타민, 셀레늄 같은 영양소들은 잠재적이며 확실한 발암물질의 억제제이기 때문이다. 더 나아가서, 일정 양의 게르마늄을 꾸준히 복용하면 돌연변이성의 인자들이 억제되는 현상을 보이고 있다.Many studies and papers recommend a balanced diet of several essential nutrients. In particular, nutrients such as antioxidants, vitamins and selenium are potential and definitive carcinogen inhibitors. Furthermore, constant doses of germanium have been shown to inhibit mutagenic factors.
Source: Department of Oral Biology, Indiana University School of Dentistry, Indianapolis 46202. Mutation Research 1995 Aug., 335(1): 21-6Source: Department of Oral Biology, Indiana University School of Dentistry, Indianapolis 46202.Mutation Research 1995 Aug., 335 (1): 21-6
수술 후의 회복과 면역력을 높이는 게르마늄Germanium improves postoperative recovery and immunity
게르마늄은 수술 후의 탐식 세포들, 백혈구의 염색질들, 혈액 주위의 림프구들, 또 이들의 콘트롤 그룹 등의 거부 반응에 대한 면역학적인 반응의 증대와 인터페론 유도체로써의 효과가 입증되었다. 게르마늄의 그런 효과들은 수술 후 오랜 기간 지속되었으며, 이러한 결과들은 수술 후의 면역 거부 반응에 대한 동물들의 실험에서 게르마늄이 수술에 따른 면역 거부 반응의 여러 임상적인 증상들에 대하여 예방과 치료제로써의 효과가 있는 것으로 보여진다.Germanium has been shown to be effective as an interferon derivative and to enhance immunological response to rejection of post-operative phagocytes, leukocyte chromatin, lymphocytes around blood, and their control groups. Such effects of germanium persisted for a long time after surgery, and these results suggest that germanium is effective as a prophylactic and therapeutic agent for several clinical symptoms of postoperative immune rejection in animals. It is shown.
Source: Journal of Veterinary Medical Science, 1993 Oct., 55(5): 795-9.Source: Journal of Veterinary Medical Science, 1993 Oct., 55 (5): 795-9.
암, 악성종양에 대한 게르마늄의 효과Effect of Germanium on Cancer and Malignant Tumors
16-19세기의 많은 연구 논문, 임상보고들에 의하면 금속, 금속성분의 화합물들이 암, 백혈병 등의 치료에 유용하다는 언급들을 하고 있다. 그러나 불행스럽게도 무기화합물, 금속화합물 등에 의해서 악성종양, 암 등이 정복될 수 있다는 사실, 즉 그런 연구들이 1960년까지는 사람들에게 잊혀지고 있었다. 게르마늄을 포함한 많은 금속화합물들이 동물들의 실험과 사람의 임상실험에서 항 암과 악성종양 제거제로써의 커다란 효과를 보여주고 있다는 사실을...... Source: European Journal of Clinical Pharmacology, 1994, 47(1):1-16Many research papers and clinical reports from the 16th and 19th centuries have mentioned that metals and metal compounds are useful in the treatment of cancer and leukemia. Unfortunately, the fact that malignant tumors, cancers, etc. can be conquered by inorganic and metal compounds, that is, such studies were forgotten by people until 1960. Many metal compounds, including germanium, have shown great effects as anticancer and malignant tumor removers in animal and human clinical trials. Source: European Journal of Clinical Pharmacology, 1994, 47 ( 1): 1-16
동물 실험에서 유기 게르마늄은 혈압을 낮추는 작용과 많은 관계가 있으며, 이러한 유기 게르마늄의 혈압 강하 작용에 대한 연구 결과들은 1979년 일본 암 협회의 도꾜에서 있었던 제 38차 연례회의의 회의록 112페이지에 나와 있다. Source: The Clinical Report (Kiso to Rinsho, in Japanese) 7(1978):719In animal experiments, organic germanium has a lot to do with blood pressure-lowering effects, and the results of these studies on the blood pressure-lowering effects of organic germanium are found in page 112 of the 38th annual meeting of the 38th Annual Meeting in Tokyo, Japan. Source: The Clinical Report (Kiso to Rinsho, in Japanese) 7 (1978): 719
유기 게르마늄은 면역 반응 체계를 완전히 상실한 노쇠한 쥐들에게서 면역 체계가 원 상태로 복구되는 것이 고찰되었다.Organic germanium has been considered to restore the immune system to its original state in older mice that have lost their immune response.
Source: International Archives of Allergy 63(1980): 338-339Source: International Archives of Allergy 63 (1980): 338-339
게르마늄은 Salmonella 구균에서 돌연변이유발에 대한 억제의 유도 작용으로써의 강력한 효능이 보여졌으며, 또한 박테리아에 대한 돌연변이유발 억제 효과들이 주목되어 졌다. Source: Mutation Research 125 (1984): 145-151Germanium has been shown to be a potent potent inhibitor of mutagenesis in Salmonella cocci, and its effects on bacteria have been noted. Source: Mutation Research 125 (1984): 145-151
유기 게르마늄은 골다공증 환자들에게 뼈의 골절 방지는 물론 골다공증을 감소시키는 것으로 나타났다.Organic germanium has been shown to reduce osteoporosis as well as bone fracture in osteoporosis patients.
Source: Asai Germanium Research Institute, Tokyo, Japan, 1984.Source: Asai Germanium Research Institute, Tokyo, Japan, 1984.
게르마늄의 경구 투여는 인터페론 유도물질이 인체 내에서 조정되어 지는 긍정적인 효과들이 있었다.Oral administration of germanium has the positive effect that the interferon inducer is regulated in the body.
Source: Microbiology and Immunology 29, 1985:65-74.Source: Microbiology and Immunology 29, 1985: 65-74.
게르마늄 산화물(유기 게르마늄)은 인체 내에서 아주 중요한 인터페론 유도체로써 작용하는 것으로 나타났다. Source: Proceedings of the Japan Cancer Association Ⅱ, Annual Meeting, 1979, Pagel93.Germanium oxide (organic germanium) has been shown to act as an important interferon derivative in the human body. Source: Proceedings of the Japan Cancer Association II, Annual Meeting, 1979, Pagel 93.
유기 게르마늄은 종양, 악성 종양을 억제시킨다는 사실이 증명되었다.Organic germanium has been shown to inhibit tumors, malignant tumors.
Source: Cancer and Chemotherapy 6, in Japanese, (1968): 79-83.Source: Cancer and Chemotherapy 6, in Japanese, (1968): 79-83.
유기 게르마늄을 경구 투여한 경우는 생명이 현저하게 연장된다는 사실이 관찰되었다. Source: Gan To Kagaku Ryoho 12, December 1985:2345-51.Oral administration of organic germanium has been observed to significantly prolong life. Source: Gan To Kagaku Ryoho 12, December 1985: 2345-51.
유기 게르마늄이 강력한 종양, 악성 종양 억제제라는 것은, 유기 게르마늄의 인터페론 유도체로써의 작용과 관련이 있는 것으로 나타났다.The fact that organic germanium is a potent tumor and malignant tumor suppressor has been shown to be related to the function of organic germanium as an interferon derivative.
Source: Tohoku Journal of Experimental Medicine 146, May 1985:97Source: Tohoku Journal of Experimental Medicine 146, May 1985: 97
종양 억제에 대한 동물 실험 결과에서, 유기 게르마늄을 투여한 동물들에게서는 종양의 자라는 것이 멈췄으며 머지 않아 종양이 줄어들었다.In animal experiments on tumor suppression, tumors stopped growing in animals administered with organic germanium and the tumors soon contracted.
Source: Anticancer Research 6, March-April 1986:177-82.Source: Anticancer Research 6, March-April 1986: 177-82.
유기 게르마늄의 치료효과에 대한 동물 실험에서 종양을 확실하게 자라지 못하도록 하는 효과를 보였다. 이런 현상들은 인체 내의 탐식세포의 활발한 활동의 결과가 효과로 나타난 것으로 보여진다. (탐식 세포도 하나의 면역 시스템이며, 그들은 적을 공격한다)Animal experiments on the therapeutic effects of organic germanium have been shown to prevent tumor growth. These phenomena appear to be the result of the active activity of the phagocytic cells in the body. (The phagocytes are also one immune system, they attack the enemy)
Source: Gan To Kagaku Ryoho 12 November 1985:2122-8.Source: Gan To Kagaku Ryoho 12 November 1985: 2122-8.
유기 게르마늄이 종양억제제로써 항암제 키모떼라피(Chemotherapy)와 함께 사용되면 어떤 결과가 나올까에 대해서 연구하게 되었다. 결과들에 의하면 종양의 성장은 정지했으며, 종양의 전이억제 효과가 있었고, 생명의 생존기간이 연장되었고, 그리고 키모떼라피(Chemotherapy)의 부작용을 줄여 주었고 아울러 항암제 사용으로 줄어든 몸무게가 회복되었다.We have studied the results of organic germanium when used with chemotherapy, an anticancer drug, as a tumor suppressor. The results showed that tumor growth stopped, tumor metastasis was inhibited, life span was prolonged, the side effects of chemotherapy were reduced, and the weight lost to chemotherapy was restored.
Source: Gan To Kagaku Ryoho 13, Aug. 1986:2588-93.Source: Gan To Kagaku Ryoho 13, Aug. 1986: 2588-93.
암 종양, 백혈병세포를 접종시킨 동물들에게 유기 게르마늄을 복용하여 치료하는 실험을 하였다. 이 연구에서 유기 게르마늄은 암 세포를 직접 공격하는 것보다는 신체의 방어기능의 향상을 통한 효과가 있는 것으로 증명되었다. 즉 탐식 세포와 T-세포들을 포함 한 면역체계의 향상을 통한 작용으로 보인다. Source: Anticancer Research 5, Sep.-Oct. 1985:479-83Animals inoculated with cancer tumors and leukemia cells were treated with organic germanium. In this study, organic germanium has been shown to be effective in improving the body's defenses rather than directly attacking cancer cells. In other words, the immune system including phagocytic cells and T-cells seems to work. Source: Anticancer Research 5, Sep.-Oct. 1985: 479-83
혈압의 변화에 대항 동물실험에서, 정상적인 혈압의 동물들에게 게르마늄을 투여한 후의 관찰에서 정상적인 혈압 그대로 아무런 변화가 없었다. 그러나 혈압이 높은 동물들에게 투여한 후에는 게르마늄을 투여한지 7-10일에 놀랍게도 혈압이 정상치로 돌아왔다. 이 효과는 게르마늄의 투여를 중단한 후로도 상당히 오랫동안 지속되었다.In animal experiments against changes in blood pressure, normal blood pressure was not changed as observed after germanium administration to animals with normal blood pressure. However, after administration to animals with high blood pressure, the blood pressure was surprisingly returned to normal 7-10 days after Germanium administration. This effect persisted for quite some time after stopping the administration of germanium.
Source: Japan Experimental Research Institute, Tokyo, Japan.Source: Japan Experimental Research Institute, Tokyo, Japan.
유기 게르마늄은 경구투여와 주사에서 똑같이 모르핀과 같은 강력한 진통효과를 보여주었다. 게르마늄을 복용 또는 투여하면 인체 내에서 엔돌핀의 생산을 늘리고, 인체의 각 감각기관들이 진통작용을 늘리는 것으로 나타났다.Organic germanium has shown the same strong analgesic effect as morphine in oral and injection. Taking or administering germanium has been shown to increase the production of endorphins in the body and to increase the analgesic effects of each organ of the body.
Source: Journal of Pharmacological Dynamics 6(1983):814-820.Source: Journal of Pharmacological Dynamics 6 (1983): 814-820.
순도가 높은 유기게르마늄은 복용 후 인체 내에서 각종 임무를 마친 후 약20-30시간 안에 인체 내에 있는 암 세포, 독소, 오염물질, 중금속 등을 붙들고 축적되는 것 없이 소변을 통해 인체에서 완전히 빠져나가므로 전혀 독성이 남지 않아 매우 안전하다.Organic germanium with high purity is completely escaped from the human body through urine without holding and accumulating cancer cells, toxins, pollutants and heavy metals in the human body within about 20-30 hours after completing various tasks in the human body after taking. It is very safe because there is no toxicity at all.
Source: Asai Germanium Research Institute, Tokyo, Japan.Source: Asai Germanium Research Institute, Tokyo, Japan.
-.본 발명은 셀레늄의 경우 Na2SeO3, Na2SeO4, 셀레늄 효모복합체, 미생물로 발효한 유기셀레늄, 각종 단백질이나 비타민등으로 킬레이팅한 유기셀레늄으로 셀레늄이 함유된 클로렐라를 배양할 수 있으며,In the present invention, in the case of selenium, chlorella containing selenium can be incubated with Na 2 SeO 3, Na 2 SeO 4, selenium yeast complex, organic selenium fermented with microorganisms, and organic selenium chelated with various proteins or vitamins.
-.게르마늄의 경우 이온화된 GeO2, Ge132와 비타민, 단백질 등으로 킬레이팅한 게르마늄 함유물질과 미생물로 발효한 게르마늄 함유물질을 이용하여 게르마늄이 함유된 클로렐라를 배양할 수 있으며,In case of germanium, germanium-containing chlorella can be cultured using ionized GeO2, Ge132, germanium-containing material chelated with vitamins and proteins, and germanium-containing material fermented with microorganisms.
-.또한 위의 방법을 혼합하면 셀레늄과 게르마늄이 동시에 함유된 클로렐라를 배양할 수 있다.In addition, the above method can be mixed to incubate chlorella containing both selenium and germanium.
본 발명에서는 Na2SeO3, Na2SeO4, 셀레늄 효모복합체, 미생물로 발효한 유기셀레늄, 각종 단백질이나 비타민등으로 킬레이팅한 유기셀레늄과 이온화된 GeO2, Ge132와 게르마늄 효모복합체, 비타민등으로 킬레이팅한 게르마늄 함유물질과 미생물로 발효한 게르마늄 함유물질을 함께 혼합하여 클로렐라를 배양할 때 셀레늄과 게르마늄 용액을 물에 적당량 첨가, 혼합하여 배양하는 것으로 셀레늄과 게르마늄 동시에 함유된 인체 흡수율이 높으며 이용성이 좋은 안전한 클로렐라를 기르는데 성공하여 본 발명을 완성하였다In the present invention, Na2SeO3, Na2SeO4, selenium yeast complex, organic selenium fermented with microorganisms, organic selenium chelated with various proteins or vitamins, and ionized GeO2, Ge132 and germanium yeast complexes, germanium-containing substances chelated with vitamins and the like When culturing chlorella by mixing together germanium-containing materials fermented with microorganisms, it is successful to cultivate safe chlorella with high absorption rate and high availability of selenium and germanium at the same time by adding and mixing appropriate amounts of selenium and germanium solution in water. To complete the present invention.
-.Na2SeO3, Na2SeO4, 셀레늄 효모복합체, 미생물로 발효한 유기셀레늄, 각종 단백질이나 비타민 등으로 킬레이팅한 유기 셀레늄 중 1종을 선택하는 단계 및;Selecting one of Na 2 SeO 3, Na 2 SeO 4, selenium yeast complex, organic selenium fermented with microorganisms, and organic selenium chelated with various proteins or vitamins;
-.이온화된 GeO2, Ge132와 게르마늄 효모복합체, 비타민 등으로 킬레이팅한 게르마늄 함유물질과 미생물로 발효한 게르마늄 함유 물질 중 1종을 선택하는 단계 및;Selecting one of ionized GeO 2, Ge132 and germanium yeast complexes, germanium-containing material chelated with vitamins, and germanium-containing material fermented with microorganisms;
-.클로렐라의 양분이 되는 배양액, (당화효소, 질소, 암모니아, 아미노산, 포도당, 과당, 맥아당, 셀레늄, 게르마늄등)을 적정하게 조성, 혼합하는 단계 및;-Appropriately formulating and mixing a culture solution that becomes a nutrient for chlorella, (glycosase, nitrogen, ammonia, amino acids, glucose, fructose, maltose, selenium, germanium, etc.);
-.햇빛이 잘 들고 25∼30℃ 온도 조건과 산소공급, 물의 회전 조건을 가진 배양조에 클로렐라와 배양액을 넣고 클로렐라를 배양하는 단계 및; 배양이 잘된 클로렐라를 회수하는 단계로 구성되며 이용성이 좋은 안전한 유기 셀레늄과 게르마늄이 동시에 함유된 클로렐라를 완성하여 본 발명을 완성하였다Culturing chlorella with chlorella and broth in a culture vessel having good sunlight and temperature conditions of 25 to 30 ° C., oxygen supply, and rotation of water; It is composed of the steps of recovering the well-cultivated chlorella and completed the present invention by completing a chlorella containing both a safe and good availability of organic selenium and germanium at the same time
이하, 본 발명을 실시예와 시험예에 의해 설명하지만, 이들에 의해 본 발명의 범위가 제한되는 것은 아니다.Hereinafter, although an Example and a test example demonstrate this invention, the scope of the present invention is not restrict | limited by these.
이하, 실시예에 따라 본 발명에 대해 구체적으로 설명한다.Hereinafter, the present invention will be described in detail with reference to Examples.
실시예 :Example
본 발명에서는 Na2SeO3, Na2SeO4, 셀레늄 효모복합체, 미생물로 발효한 유기셀레늄, 각종 단백질이나 비타민등으로 킬레이팅한 유기셀레늄이 사용될 수 있지만 바람직하게 Na2SeO3를 선택하여 사용하였고,In the present invention, Na 2 SeO 3, Na 2 SeO 4, selenium yeast complex, organic selenium fermented with microorganisms, and organic selenium chelated with various proteins or vitamins may be used, but preferably Na 2 SeO 3 is selected and used.
게르마늄의 경우 무기태의 이온화된 GeO2, Ge132와 게르마늄 효모복합체, 비타민등으로 킬레이팅한 게르마늄 함유물질과 미생물로 발효한 게르마늄 함유물질을 사용할 수 있지만 게르마늄의 경우 Ge132를 선택하여 사용하였다.For germanium, germanium-containing materials chelated with inorganic ionized GeO2, Ge132 and germanium yeast complexes, vitamins, and germanium-containing materials fermented with microorganisms can be used, but for germanium, Ge132 was selected.
선택된 셀레늄과 게르마늄을 이온화 한 다음 클로렐라의 양분으로 조성된 배양액 1톤을 기준으로 셀레늄(0.1ppm)과 게르마늄(0.0lppm)을 혼합하였고 25∼30℃의 배양조에서 본 출원자가 고안하여 실용신안으로 등록된(등록번호: 03l879l호)공기정화기를 이용하여 무균상태로 정화된 산소를 공급하면서 회전축을 이용하여 물을 회전 시키면서 조명을 비추어 클로렐라의 광합성을 도우면서 클로렐라를 배양한 후 원심분리기를 이용하여 클로렐라를 분리시켜 침강된 클로렐라를 회수하여 셀레늄과 게르마늄 용액을 첨가하여 배양된 클로렐라에 셀레늄은 0.8mg/kg 게르마늄은 0.05mg/kg을 검출하였다. 클로렐라는 단백질, 엽록소, 탄소화물, 미네랄, 비타민등을 함유하고 있으나 그 질이나 양으로 보아 다른 식물보다 월등하게 우수하다. 클로렐라에는 C, G, F(성장촉진인자)라는 특수 물질이 함유되어 있어 공해를 이겨내는 식품이므로 건강의 태양이라고 극찬하는 이도 있다.Ionized the selected selenium and germanium, and then mixed selenium (0.1ppm) and germanium (0.0lppm) on the basis of 1 ton of the culture solution composed of chlorella nutrients. Using the air purifier registered (Registration No .: 03l879l), supplying purified oxygen in a sterile state while rotating the water using a rotating shaft to illuminate the chlorella while helping to chlorella's photosynthesis, and then using a centrifuge Chlorella was isolated to recover the precipitated chlorella, and 0.8 mg / kg of selenium and 0.05 mg / kg of germanium were detected in the cultured chlorella by adding a selenium and germanium solution. Chlorella contains protein, chlorophyll, carbohydrates, minerals and vitamins, but it is superior to other plants in terms of quality and quantity. Chlorella contains special substances such as C, G, and F (growth growth factors), which are foods that overcome the pollution.
아래의 표는 클로렐라의 영양 분석표이며, 본 발명으로 인해 클로렐라에 무기 영양소 셀레늄과 게르마늄을 함유하게 되었으며The table below is a nutritional analysis table of chlorella, and the present invention includes chlorella with inorganic nutrients selenium and germanium.
인체 흡수율이 높으며 이용성이 좋은 안전한 클로렐라를 완성하여 본 발명을 완성하였다.The present invention was completed by completing a safe chlorella having high human absorption rate and good usability.
본 발명에 따라 배양된 클로렐라에는 항암, 항산화 효과가 있는 식물성 유기셀레늄과 식물성 유기 게르마늄이 다량 함유되어 동물의 사료 및 음식물의 재료로 사용하여 독성이 없고 치료 및 예방효과가 있는, 인체에 유익한 식물성 유기 셀레늄과 게르마늄을 자연스럽게 있는 섭취할 수 있게 되었다.Chlorella cultured according to the present invention contains a large amount of vegetable organic selenium and vegetable organic germanium which have anti-cancer and antioxidant effects, so that it is not toxic and has a therapeutic and preventive effect. Selenium and germanium are naturally available.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050011806A KR20050032050A (en) | 2005-02-14 | 2005-02-14 | Culture method of chlorella containing selenium and germanium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050011806A KR20050032050A (en) | 2005-02-14 | 2005-02-14 | Culture method of chlorella containing selenium and germanium |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20050032050A true KR20050032050A (en) | 2005-04-06 |
Family
ID=37236662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050011806A KR20050032050A (en) | 2005-02-14 | 2005-02-14 | Culture method of chlorella containing selenium and germanium |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20050032050A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100950159B1 (en) * | 2008-01-22 | 2010-03-30 | 문기혁 | Environmental frendly Method of production of Selenium enriched Photo-synthetic Bacteria and Farm products Using by it's |
CN102815973A (en) * | 2011-06-07 | 2012-12-12 | 山西昌鑫生物农业科技有限公司 | Preparation method of biological selenium-rich fertilizer |
WO2018199723A3 (en) * | 2017-04-28 | 2019-05-23 | 한남바이오 주식회사 | Selenium resistive novel microalgae |
-
2005
- 2005-02-14 KR KR1020050011806A patent/KR20050032050A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100950159B1 (en) * | 2008-01-22 | 2010-03-30 | 문기혁 | Environmental frendly Method of production of Selenium enriched Photo-synthetic Bacteria and Farm products Using by it's |
CN102815973A (en) * | 2011-06-07 | 2012-12-12 | 山西昌鑫生物农业科技有限公司 | Preparation method of biological selenium-rich fertilizer |
WO2018199723A3 (en) * | 2017-04-28 | 2019-05-23 | 한남바이오 주식회사 | Selenium resistive novel microalgae |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghaeni et al. | Review for application and medicine effects of Spirulina, microalgae | |
KR20040071086A (en) | Cultivation of plants containing simultaneously containing germanium and selenium | |
KR101695038B1 (en) | Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy | |
KR20050010990A (en) | Production of germinated brown rice containing germanium and selenium by soaking rice in water containing germanium and selenium and germinating | |
CN107223986A (en) | A kind of selenium-rich health-care polypeptide product and preparation method thereof | |
KR20050012855A (en) | Method for preparing animal fodder containing organic germanium and organic selenium having no toxicity and antioxidative and anticancer activity | |
CN105475636A (en) | Water-soluble garlicin mixture, and preparation method and use thereof | |
KR20050027238A (en) | Cultivation method of sprout vegetables containing selenium and germanium | |
KR20050032050A (en) | Culture method of chlorella containing selenium and germanium | |
KR100408011B1 (en) | Media composition containing selenium source for cultivating mushroom, method for preparing the same, and seleniumcontaining mushroom produced using the same | |
GB2214928A (en) | Processing for preparing algae having improved biological effects | |
CN107087784A (en) | A kind of preparation method of the maltodextrin comprising L methylselenocysteinefroms | |
CN105558435A (en) | Feed additive for preventing and treating silver carp hemorrhagic disease | |
KR100889830B1 (en) | Mineral animal feed | |
KR20050027237A (en) | How to grow herbs containing selenium and germanium | |
KR20050032547A (en) | Manufacturing method of porridge containing vegetable organic selenium and germanium | |
KR20040071089A (en) | Cultivation of mulberry tree containing selenium and germanium | |
KR20040075796A (en) | Production of milk product containing germanium and selenium | |
KR100814012B1 (en) | Manufacturing process of Chitosan-Selenium Complex | |
KR20050032051A (en) | Method for preparing gimbap containing vegetable organic selenium and germanium | |
KR20040052744A (en) | Method for cultivating watermelon containing germanium | |
KR20040072534A (en) | Production of fermented soy products containing germanium and selenium | |
Kerna et al. | J.“Spirulina Consumption: Concerns Regarding Contaminants and Uncommon but Possible Adverse Reactions and Interactions” | |
KR20200080839A (en) | process of culturing | |
KR20050030911A (en) | Manufacturing method of dumplings containing vegetable organic selenium and germanium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |